3,638 followers
Patient-Reported Outcomes and Quality of Life with Sunitinib Versus Placebo for Pancreatic Neuroendocrine Tumors: Re…https://t.co/DfJDi4YeTY
Patient-Reported Outcomes and Quality of Life with Sunitinib Versus Placebo for Pancreatic Neuroendocrine Tumors: Re…https://t.co/DfJDi4YeTY
Patient-Reported Outcomes and Quality of Life with Sunitinib Versus Placebo for Pancreatic Neuroendocrine Tumors: Re…https://t.co/gFe4uR1Bqa
RT @TargetOncology: PROs and HRQoL with Sunitinib Versus Placebo for Pancreatic NETs: Results From an International Phase III Trial https:/…
PROs and HRQoL with Sunitinib Versus Placebo for Pancreatic NETs: Results From an International Phase III Trial https://t.co/RwXOKh6iB0